secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASP Isotopes Inc. (ASPI)
CIK:        0001921865
Form:       8-K
Filed at:   2026-01-30T23:59:59+00:00
Accession:  0001477932-26-000555
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

ASP Isotopes invests ~$10M in Opeongo, gets right of first offer on medical isotope supply
--------------------------------------------------------------------------------

- Purchased 4,356,918 Series Seed-1 Preferred shares of Opeongo at $2.2952 per share (approx $10M investment).
- Opeongo is a biotech developing ECM modulators for fibrosis, inflammation, and cancer; co-founded by David Baram and Irit Sagi.
- ASPI secures right of first offer to supply medical isotopes for any Opeongo pharmaceutical product (supply agreement to be negotiated).
- Related party: ASPI CEO Paul Mann designated as Series Seed-1 Director of Opeongo; CMO Todd Wider also a director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1921865/000147793226000555/0001477932-26-000555-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1921865/000147793226000555/aspi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-26-000555

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer